Dyno Therapeutics and Spark Therapeutics have to navigate coopetition, gate sensitive IP, and uneven scientific results, but this drug development platform technology alliance is off to a good start thanks to a harmonious working relationship and a commitment to improving patients' lives. Continue Reading
When it's time to enter new markets around the globe, the alliance manager can add tremendous value by learning the regulatory commercial, and geopolitical landscape of the desired new regions, according to a 2023 ASAP BioPharma Conference panel. Continue Reading
With nearly three decades in the tech world, including alliances and ecosystems, ASAP's newest board member, Nicole Colwell, is set to bring new viewpoints to the table, including a focus on DEI, as well as unique insights from an emerging area of technology. Continue Reading
Ameriga Fanigliulo showed ASAP BioPharma Conference attendees how her company salvaged a collaboration that encountered an issue that threatened the viability of the alliance. Continue Reading
It's meetings, but it's more than that. It involves talking, sure, but mostly a lot of listening. It's how decisions get made, and it may mean the difference between an alliance that "has legs" and one that goes exactly nowhere. What is it? Tech alliance governance, as a recent ASAP Webinar showed. Continue Reading
If you don’t have trust, you don’t have a collaborative relationship. So said Frank Lee as part of the November Collaborative Connection Monthly webinar and roundtable. Continue Reading
Meet Nicole Boston, ASAP's new CEO! Continue Reading
Some alliance managers had a mentor when they began their alliance careers, others were "pushed into the pool." Videos, organization curricula, and ASAP tools have helped many an alliance professional swim in the partnership waters. ASAP's latest roundtable dove into mentoring. Continue Reading
With the impending retirement later this month of ASAP president and CEO Michael Leonetti, CSAP, “a key feature of our alliance community” is moving on, ushering in a new era for ASAP. That was the description given by Brooke Paige, CSAP, digital alliance leader at Novartis, as she... Continue Reading
Change is a constant in biopharma partnering, and a panel of alliance leaders examined the skills and capabilities needed to confront the ongoing challenges on opening day of the 2023 ASAP BioPharma Conference in Boston. Continue Reading
Day 2 of the 2023 ASAP BioPharma Conference kicked off with a panel exploring the world of drug development technology platform alliances—multiple programs, therapeutic areas, and indications. IP protection, stakeholder management, and surprises, big and small, put alliance managers to the test. Continue Reading
Empathy helps helps drive powerful outcomes for patients and consumers—and great business outcomes! So said Doug Wenners during his ASAP BioPharma Conference keynote presentation. Continue Reading
